Jeremy Bastid, Chief Development Officer of ORPHELIA Pharma, will attend the 2018 BIO International Convention, to be held in Boston, Massachusetts, June 4-7, 2018.

Please meet us there on June 6 or 7 (contact: jeremy.bastid@orphelia-pharma.eu)

Jeremy Bastid, Chief Development Officer of ORPHELIA Pharma, will attend the 2018 ASCO annual meeting to be held in Chicago, Illinois, June 1-5, 2018.

Please meet us there (contact: jeremy.bastid@orphelia-pharma.eu).

Jeremy Bastid, Chief Development Officer of ORPHELIA Pharma, will attend the Advances in Neuroblastoma Research (ANR) 2018 conference, “Building Bridges for Neuroblastoma Research” in San Francisco, California from May 9-12, 2018.

Please meet us there (contact: jeremy.bastid@orphelia-pharma.eu).